These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 35227758)
1. Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells. Perera N; Brun J; Alonzi DS; Tyrrell BE; Miller JL; Zitzmann N Antiviral Res; 2022 Mar; 199():105269. PubMed ID: 35227758 [TBL] [Abstract][Full Text] [Related]
2. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus. Durantel D; Branza-Nichita N; Carrouée-Durantel S; Butters TD; Dwek RA; Zitzmann N J Virol; 2001 Oct; 75(19):8987-98. PubMed ID: 11533162 [TBL] [Abstract][Full Text] [Related]
3. Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus. Miller JL; Hill ML; Brun J; Pountain A; Sayce AC; Zitzmann N Antiviral Res; 2019 Oct; 170():104551. PubMed ID: 31306674 [TBL] [Abstract][Full Text] [Related]
4. Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes. Sayce AC; Alonzi DS; Killingbeck SS; Tyrrell BE; Hill ML; Caputo AT; Iwaki R; Kinami K; Ide D; Kiappes JL; Beatty PR; Kato A; Harris E; Dwek RA; Miller JL; Zitzmann N PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004524. PubMed ID: 26974655 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus. Miller JL; Tyrrell BE; Zitzmann N Adv Exp Med Biol; 2018; 1062():277-301. PubMed ID: 29845540 [TBL] [Abstract][Full Text] [Related]
6. Strain-specific antiviral activity of iminosugars against human influenza A viruses. Hussain S; Miller JL; Harvey DJ; Gu Y; Rosenthal PB; Zitzmann N; McCauley JW J Antimicrob Chemother; 2015 Jan; 70(1):136-52. PubMed ID: 25223974 [TBL] [Abstract][Full Text] [Related]
7. Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo. Miller JL; Lachica R; Sayce AC; Williams JP; Bapat M; Dwek R; Beatty PR; Harris E; Zitzmann N Antimicrob Agents Chemother; 2012 Dec; 56(12):6379-86. PubMed ID: 23070155 [TBL] [Abstract][Full Text] [Related]
8. Antiviral effects of an iminosugar derivative on flavivirus infections. Wu SF; Lee CJ; Liao CL; Dwek RA; Zitzmann N; Lin YL J Virol; 2002 Apr; 76(8):3596-604. PubMed ID: 11907199 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of α-glucosidase activity by N-deoxynojirimycin analogs in several insect phloem sap feeders. Ya'kobovitz MK; Butters TD; Cohen E Insect Sci; 2016 Feb; 23(1):59-67. PubMed ID: 25900765 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4. Warfield KL; Plummer EM; Sayce AC; Alonzi DS; Tang W; Tyrrell BE; Hill ML; Caputo AT; Killingbeck SS; Beatty PR; Harris E; Iwaki R; Kinami K; Ide D; Kiappes JL; Kato A; Buck MD; King K; Eddy W; Khaliq M; Sampath A; Treston AM; Dwek RA; Enterlein SG; Miller JL; Zitzmann N; Ramstedt U; Shresta S Antiviral Res; 2016 May; 129():93-98. PubMed ID: 26946111 [TBL] [Abstract][Full Text] [Related]
11. ToP-DNJ, a Selective Inhibitor of Endoplasmic Reticulum α-Glucosidase II Exhibiting Antiflaviviral Activity. Kiappes JL; Hill ML; Alonzi DS; Miller JL; Iwaki R; Sayce AC; Caputo AT; Kato A; Zitzmann N ACS Chem Biol; 2018 Jan; 13(1):60-65. PubMed ID: 29161006 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection. Yu W; Gill T; Wang L; Du Y; Ye H; Qu X; Guo JT; Cuconati A; Zhao K; Block TM; Xu X; Chang J J Med Chem; 2012 Jul; 55(13):6061-75. PubMed ID: 22712544 [TBL] [Abstract][Full Text] [Related]
13. Pathogen-induced inflammation is attenuated by the iminosugar MON-DNJ via modulation of the unfolded protein response. Sayce AC; Martinez FO; Tyrrell BE; Perera N; Hill ML; Dwek RA; Miller JL; Zitzmann N Immunology; 2021 Nov; 164(3):587-601. PubMed ID: 34287854 [TBL] [Abstract][Full Text] [Related]
14. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions. Chang J; Block TM; Guo JT Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo. Warfield KL; Warren TK; Qiu X; Wells J; Mire CE; Geisbert JB; Stuthman KS; Garza NL; Van Tongeren SA; Shurtleff AC; Agans KN; Wong G; Callahan MV; Geisbert TW; Klose B; Ramstedt U; Treston AM Antiviral Res; 2017 Feb; 138():22-31. PubMed ID: 27908828 [TBL] [Abstract][Full Text] [Related]
16. Novel imino sugar α-glucosidase inhibitors as antiviral compounds. Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447 [TBL] [Abstract][Full Text] [Related]
17. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Zitzmann N; Mehta AS; Carrouée S; Butters TD; Platt FM; McCauley J; Blumberg BS; Dwek RA; Block TM Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11878-82. PubMed ID: 10518544 [TBL] [Abstract][Full Text] [Related]
18. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors. Chapel C; Garcia C; Bartosch B; Roingeard P; Zitzmann N; Cosset FL; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D J Gen Virol; 2007 Apr; 88(Pt 4):1133-1143. PubMed ID: 17374756 [TBL] [Abstract][Full Text] [Related]
19. The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy. Ouzounov S; Mehta A; Dwek RA; Block TM; Jordan R Antiviral Res; 2002 Sep; 55(3):425-35. PubMed ID: 12206880 [TBL] [Abstract][Full Text] [Related]